National Research (NASDAQ:NRC) Stock Crosses Above 200-Day Moving Average – Should You Sell?

National Research Corporation (NASDAQ:NRC) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $17.16 and traded as high as $19.68. National Research shares last traded at $19.04, with a volume of 75,438 shares changing hands.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered shares of National Research from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, March 6th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of “Sell”.

National Research Price Performance

The company has a market cap of $433.99 million, a PE ratio of 48.92 and a beta of 0.31. The business’s 50 day moving average price is $17.66 and its 200-day moving average price is $17.17. The company has a quick ratio of 0.52, a current ratio of 0.52 and a debt-to-equity ratio of 5.48.

National Research (NASDAQ:NRC) last posted its quarterly earnings data on Tuesday, April 28th. The company reported $0.21 earnings per share (EPS) for the quarter. The company had revenue of $34.80 million for the quarter. National Research had a net margin of 6.52% and a return on equity of 122.73%.

National Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 10th. Shareholders of record on Friday, June 26th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date of this dividend is Friday, June 26th. National Research’s payout ratio is currently 164.10%.

Hedge Funds Weigh In On National Research

Several hedge funds and other institutional investors have recently modified their holdings of NRC. Cubist Systematic Strategies LLC acquired a new position in shares of National Research during the first quarter valued at $118,000. AQR Capital Management LLC boosted its holdings in shares of National Research by 168.6% during the first quarter. AQR Capital Management LLC now owns 108,134 shares of the company’s stock valued at $1,384,000 after acquiring an additional 67,882 shares during the period. Jane Street Group LLC boosted its holdings in shares of National Research by 394.2% during the first quarter. Jane Street Group LLC now owns 52,411 shares of the company’s stock valued at $671,000 after acquiring an additional 41,806 shares during the period. Strs Ohio acquired a new position in shares of National Research during the first quarter valued at $33,000. Finally, M&T Bank Corp boosted its holdings in shares of National Research by 6.4% during the second quarter. M&T Bank Corp now owns 13,608 shares of the company’s stock valued at $229,000 after acquiring an additional 823 shares during the period. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.